OR
MEDP icon

Olympiad Research’s Medpace MEDP Stock Holding History

Olympiad Research’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-362
Closed -$203K – 122
2025
Q4 		$203K Buy
+362
New +$205K 0.54% 73
2025
Q1 		– Sell
-680
Closed -$226K – 323
2024
Q4 		$226K Sell
680
-214
-24% -$72.6K 0.24% 166
2024
Q3 		$298K Buy
894
+312
+54% +$119K 0.19% 184
2024
Q2 		$240K Buy
582
+39
+7% +$15.4K 0.18% 227
2024
Q1 		$219K Buy
+543
New +$191K 0.14% 286
2023
Q4 		– Sell
-1,441
Closed -$349K – 385
2023
Q3 		$349K Sell
1,441
-26
-2% -$6.65K 0.34% 86
2023
Q2 		$352K Buy
+1,467
New +$305K 0.35% 85

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Olympiad Research's MEDP Position: Q1 2026 in Review

Olympiad Research sold out of Medpace (MEDP) in Q1 2026, closing a stake of 362 shares — an estimated $203K sold.

Olympiad Research first reported a position in MEDP in Q2 2023 and held it in 7 quarters. The position peaked at $352K in Q2 2023. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Olympiad Research reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Olympiad Research sold 362 Medpace shares in Q1 2026, an estimated $203K.
  • Olympiad Research first reported a position in Medpace in Q2 2023 and held it in 7 quarters.
  • Olympiad Research's Medpace position peaked at $352K in Q2 2023.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Olympiad Research's 13F filing for Q1 2026, filed 13 May 2026.